ストックスクリーナーアプリを入手
11.13
2.11%
-0.24
アフターアワーズ：
11.13
Roivant Sciences Ltd (ROIV) 最新ニュース
Roivant Sciences (NASDAQ:ROIV) Upgraded to "Strong-Buy" at Cantor Fitzgerald - MarketBeat
Trump Index: 6 Companies Linked to Trump’s Cabinet Worth Watching - MarketBeat
Trump Index: 6 Companies Linked to Trump's Cabinet Worth Watching - Benzinga
Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Roivant sciences president Eric Venker sells $1.13 million in shares - MSN
Zweig DiMenna Associates LLC Takes Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Roivant Sciences Ltd. (NASDAQ:ROIV) COO Sells $1,128,000.00 in Stock - MarketBeat
Why Is Andreas Halvorsen Bullish On Roivant Sciences Ltd. (ROIV) Now? - Yahoo Finance
How Rich Is This Indian-Origin Entrepreneur Who Took On Donald Trump But Is Now…? Check His Net Worth - News24
What Is Vivek Ramaswamy’s net worth? The Indian American man who took on Trump and then became a confidante - The Financial Express
Trump Inauguration: Who Is Vivek Ramaswamy and what’s his role in Trump 2.0? - The Financial Express
Roivant Sciences Sees Unusually High Options Volume (NASDAQ:ROIV) - MarketBeat
Roivant Sciences Ltd. Trade Ideas — LS:A3C4MS - TradingView
Roivant sciences increases stake in Immunovant with $336.9 million purchase - Investing.com India
Roivant Sciences Ltd. (NASDAQ:ROIV) Director Acquires $336,900,200.00 in Stock - MarketBeat
Roivant sciences increases stake in Immunovant with $336.9 million purchase By Investing.com - Investing.com Nigeria
Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Acquired by JPMorgan Chase & Co. - Defense World
Is Roivant Sciences (ROIV) the Best Medical Stock to Buy Under $20? - Insider Monkey
12 Best Medical Stocks To Buy Under $20 - Insider Monkey
Nordea Investment Management AB Raises Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
ROIVWroivw Latest Stock News & Market Updates - StockTitan
ROIV Crosses Below Key Moving Average Level - Nasdaq
Arbutus could benefit from Big Pharma bird flu vaccines: Jefferies - MSN
Why Ramaswamy Says America Needs a Cultural Shift Towards Excellence for the Sake of US Students - The Times of India
Roivant Sciences Ltd. (NASDAQ:ROIV) Receives $17.93 Consensus Target Price from Analysts - MarketBeat
Roivant Sciences Ltd. (NASDAQ:ROIV) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Why Roivant Sciences Ltd. (ROIV) Is Skyrocketing - Yahoo Finance
10 Firms End 2024 Stronger With Impressive Gains - Insider Monkey
Strategic Sale: Eric Venker Decides To Exercise Options Worth $3.86M At Roivant Sciences - Benzinga
Roivant Sciences Ltd. (NASDAQ:ROIV) COO Sells $2,050,704.16 in Stock - MarketBeat
Insider Selling: Roivant Sciences Ltd. (NASDAQ:ROIV) COO Sells 176,900 Shares of Stock - MarketBeat
Roivant Sciences' president sells common shares worth $4.1 million - Investing.com India
Principal Financial Group Inc. Has $11.65 Million Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Roivant Sciences' CIO Mayukh Sukhatme sells $10.6m in shares - Investing.com India
Eric Venker Sells 100,000 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) Stock - MarketBeat
Insider Selling: Roivant Sciences Ltd. (NASDAQ:ROIV) CIO Sells 689,495 Shares of Stock - MarketBeat
Mayukh Sukhatme Sells 185,946 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) Stock - MarketBeat
Roivant sciences president Eric Venker sells $1.15 million in shares By Investing.com - Investing.com Nigeria
Roivant Sciences’ CIO Mayukh Sukhatme sells $10.6m in shares By Investing.com - Investing.com Nigeria
Roivant Sciences' CIO Mayukh Sukhatme sells $10.6m in shares By Investing.com - Investing.com South Africa
Roivant sciences president Eric Venker sells $1.15 million in shares - Investing.com
Barclays PLC Buys 75,609 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Mayukh Sukhatme Sells 412,584 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) Stock - MarketBeat
3.95%
2.39%
大文字化:
|
ボリューム (24 時間):